September 19, 2024 by University of Connecticut Accumulation of lineage-associated and population-associated missense mutations in select TPA proteins. Credit: The Lancet Microbe (2024). DOI: 10.1016/S2666-5247(24)00087-9Syphilis cases have surged worldwide, leaving public health officials scrounging for ways to stop the spread. Now, a large, collaborative study of syphilis genetics from four continents has found hints of...
Tag: <span>Vaccine</span>
Critical immune factor for host defense against MRSA offers potential explanation for unsuccessful vaccine strategies
September 17, 2024 by Amsterdam University Medical Centers A colorized scanning electron micrograph of MRSA. Credit: National Institute of Allergy and Infectious DiseasesStaphylococcus aureus, mostly known from its antibiotic-resistant variant methicillin-resistant Staphylococcus aureus (MRSA), is among the leading causes of both community- and hospital-acquired infections. According to the most recent data, MRSA killed around 120,000...
Healthcare workers unprepared for mpox outbreak due to knowledge gaps and vaccine inequity
By Dr. Sanchari Sinha Dutta, Ph.D. Aug 27 2024 Study: International healthcare workers’ experiences and perceptions of the 2022 multi-country mpox outbreak. Image Credit: Corona Borealis Studio / Shutterstock *Important notice: medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as...
COVID summer guide: How to navigate symptoms, variants and vaccines this season amid rising cases
Updated July 5, 2024 Experts are beginning to see signs of the usual summer COVID surge. They have tips on what you need to know this season. (Getty Images)It’s summer 2024, but the COVID-19 pandemic is still hanging around. And while the virus continues to evolve, it’s doing so in more predictable ways. Specifically, the...
New ‘vaccine-like’ HIV drug could cost just $40: Researchers
JULY 23, 2024 HIV infecting a human cell. Credit: NIHA new “vaccine-like” HIV drug that currently costs over $40,000 per person a year could be made for as little as $40, researchers estimated on Tuesday. The antiretroviral drug Lenacapavir, developed by US pharmaceutical giant Gilead, has been hailed as a potential game-changer in the fight...
An outdated vaccine could be to blame for LA’s COVID surge
An outdated vaccine could be to blame for LA’s COVID surgeRelaxed public measures, a new variant, and increased travel are also likely contributors to LA’s rising COVID cases.By Amber X. Chen • Published July 8, 2024 • Updated 2 hours agoCOVID-19 cases are on the rise in LA County and California. Colleen Williams and Annabelle...
What’s Next for the World’s First HIV Vaccine?
Allison Shelley When the world needed a COVID vaccine, leading HIV investigators answered the call to intervene in the coronavirus pandemic. Now, efforts to discover the world’s first HIV vaccine are revitalized. “The body is capable of making antibodies to protect us from HIV,” says Yunda Huang, PhD, from the Fred Hutchinson Cancer Center in...
Covid-19 increases risk of developing autoimmune disease, but vaccination helps, large study shows
By Isabella Cueto Dozens of commuters, wearing face masks, swarm toward a descending escalator at a train station in Tokyo, Japan — politics coverage from STATPeople wearing face masks pass through a train station in Tokyo, Japan.CARL COURT/GETTY IMAGESHaving Covid-19 increases a person’s risk of developing an autoimmune disease in the year after infection, a...
Study: ‘Hexaplex’ vaccine aims to boost flu protection
by Cory Nealon, University at Buffalo Graphical Abstract. Credit: Cell Reports Medicine (2024). DOI: 10.1016/j.xcrm.2024.101433Recombinant protein vaccines, like the Novavax vaccine used to fight COVID-19, offer several advantages over conventional vaccines. They’re easy to produce precisely. They’re safe and potentially more effective. And they could require smaller doses. Because of these traits, there is much interest...
Fighting the flu: The surprising power of a century-old vaccine for tuberculosis
by Keila DePape, McGill University a, The mouse model of BCG vaccination and IAV infection. b,c, Morbidity and mortality of mice infected with the lethal dose of PR8 (120 PFUs; n = 9–10). d, Viral load at various timepoints after infection with a sublethal dose of IAV-PR8 (50 PFUs; n = 4–8). e, Confocal microscopy of lung section infected with...